|
Volumn 100, Issue 7, 2006, Pages 1187-1193
|
Insulin-sensitizing and cholesterol-lowering effects of chromium (d-Phenylalanine)3
|
Author keywords
Chromium; Diabetes; Hyperlipidemia; Insulin; Obesity; Oxidant stress
|
Indexed keywords
ANTILIPEMIC AGENT;
CHOLESTEROL;
CHROMIUM DERIVATIVE;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LIPID;
PHENYLALANINE DERIVATIVE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
COMPARATIVE STUDY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DIABETES CONTROL;
DIABETIC OBESITY;
DISEASE ASSOCIATION;
DRUG STRUCTURE;
DYSLIPIDEMIA;
GLUCOSE BLOOD LEVEL;
HYPERLIPIDEMIA;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIPID BLOOD LEVEL;
LIPID PEROXIDATION;
MALE;
MOUSE;
MOUSE STRAIN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
ORAL GLUCOSE TOLERANCE TEST;
OXIDATIVE STRESS;
STRUCTURE ANALYSIS;
THERAPY EFFECT;
TREATMENT RESPONSE;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
BLOOD GLUCOSE;
BLOTTING, WESTERN;
BODY WEIGHT;
CHOLESTEROL;
ELECTROPHORESIS, POLYACRYLAMIDE GEL;
INSULIN RESISTANCE;
LIPID PEROXIDATION;
LIVER;
MALE;
MICE;
ORGANOMETALLIC COMPOUNDS;
PHENYLALANINE;
PHOSPHORYLATION;
PROTO-ONCOGENE PROTEINS C-AKT;
|
EID: 33744524794
PISSN: 01620134
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jinorgbio.2006.01.039 Document Type: Article |
Times cited : (55)
|
References (23)
|